Patents by Inventor Michael Dauner

Michael Dauner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220204966
    Abstract: Evolved strains of Bifidobacterium and Lactobacillus are provided. The evolved strains have probiotic properties and have enhanced storage stability in both wet and dry conditions. The strains of the invention contain key genetic mutations and phenotypic alterations as compared with wild-type.
    Type: Application
    Filed: April 23, 2020
    Publication date: June 30, 2022
    Inventors: Michael DAUNER, Gerda SAXER QUANCE, Steven Keith WILLIAMS
  • Patent number: 10006058
    Abstract: The present invention is related to recombinant host cells comprising: (i) at least one deletion, mutation, and/or substitution in an endogenous gene encoding a polypeptide that converts pyruvate to acetaldehyde, acetyl-phosphate or acetyl-CoA; and (ii) a heterologous polynucleotide encoding a polypeptide having phosphoketolase activity. The present invention is also related to recombinant host cells further comprising (iii) a heterologous polynucleotide encoding a polypeptide having phosphotransacetylase activity.
    Type: Grant
    Filed: December 12, 2016
    Date of Patent: June 26, 2018
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Michael Dauner, Lori Ann Maggio-Hall, Jean-Francois Tomb
  • Patent number: 9944954
    Abstract: Provided herein are glycerol-3-phosphate dehydrogenase (GPD) enzymes with increased KM for NADH and GPD enzymes with substantially the same affinity for NADH and NADPH and/or are feedback inhibited by glycerol-3-phosphate. Also provided herein are recombinant microorganisms comprising a heterologous gene encoding GPD and a deletion or disruption in an endogenous gene encoding GPD. Also provided are recombinant microorganisms comprising a heterologous gene encoding GPD and a butanol biosynthetic pathway. Further provided are methods of producing butanol comprising providing the recombinant microorganisms described herein and contacting the recombinant microorganism with at least one fermentable carbon substrate under conditions wherein butanol is produced.
    Type: Grant
    Filed: August 4, 2016
    Date of Patent: April 17, 2018
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Ritu Bhalla, Gopal K. Chotani, Michael Dauner, Mark J. Nelson, Daniel P. O'Keefe, Caroline M. Peres, Jahnavi Chandra Prasad, Jean-Francois Tomb
  • Patent number: 9771602
    Abstract: Provided herein are recombinant yeast host cells and methods for their use for production of fermentation products. Host cells provided herein comprise a pyruvate-utilizing pathway and a competitive growth advantage over other microorganisms in solution.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 26, 2017
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Larry Cameron Anthony, Michael Dauner
  • Patent number: 9701989
    Abstract: Recombinant microbial cells are disclosed herein that produce an oil comprising at least 28 percent eicosapentaenoic acid (EPA) measured as a weight percent of dry cell weight. These cells may comprise a polynucleotide sequence encoding an active acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT) comprising at least one amino acid mutation in a membrane-bound O-acyltransferase motif. In addition, the cells may comprise a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein, and/or one or more polynucleotides encoding phospholipid:diacylglycerol acyltransferase (PDAT), delta-12 desaturase, a dihomo-gamma-linolenic acid (DGLA) synthase multizyme, delta-8 desaturase, malonyl-CoA synthetase (MCS), or acyl-CoA:lysophosphatidic acid acyltransferase (LPAAT). Also disclosed are methods of using the recombinant microbial cells to produce oil containing omega-3 polyunsaturated fatty acids such as EPA.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: July 11, 2017
    Assignee: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: Quinn Qun Zhu, Seung-Pyo Hong, Pamela L Sharpe, Narendra S Yadav, Xiaochun Fan, Michael Dauner
  • Publication number: 20170088863
    Abstract: The present invention is related to recombinant host cells comprising: (i) at least one deletion, mutation, and/or substitution in an endogenous gene encoding a polypeptide that converts pyruvate to acetaldehyde, acetyl-phosphate or acetyl-CoA; and (ii) a heterologous polynucleotide encoding a polypeptide having phosphoketolase activity. The present invention is also related to recombinant host cells further comprising (iii) a heterologous polynucleotide encoding a polypeptide having phosphotransacetylase activity.
    Type: Application
    Filed: December 12, 2016
    Publication date: March 30, 2017
    Inventors: Michael Dauner, Lori Ann Maggio-Hall, Jean-Francois Tomb
  • Patent number: 9550999
    Abstract: The present invention is related to recombinant host cells comprising: (i) at least one deletion, mutation, and/or substitution in an endogenous gene encoding a polypeptide that converts pyruvate to acetaldehyde, acetyl-phosphate, or acetyl-CoA; and (ii) a heterologous polynucleotide encoding a polypeptide having phosphoketolase activity. The present invention is also related to recombinant host cells further comprising (iii) a heterologous polynucleotide encoding a polypeptide having phosphotransacetylase activity.
    Type: Grant
    Filed: July 18, 2014
    Date of Patent: January 24, 2017
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Michael Dauner, Lori Ann Maggio-Hall, Jean-Francois Tomb
  • Publication number: 20160376613
    Abstract: Provided herein are glycerol-3-phosphate dehydrogenase (GPD) enzymes with increased KM for NADH and GPD enzymes with substantially the same affinity for NADH and NADPH and/or are feedback inhibited by glycerol-3-phosphate. Also provided herein are recombinant microorganisms comprising a heterologous gene encoding GPD and a deletion or disruption in an endogenous gene encoding GPD. Also provided are recombinant microorganisms comprising a heterologous gene encoding GPD and a butanol biosynthetic pathway. Further provided are methods of producing butanol comprising providing the recombinant microorganisms described herein and contacting the recombinant microorganism with at least one fermentable carbon substrate under conditions wherein butanol is produced.
    Type: Application
    Filed: August 4, 2016
    Publication date: December 29, 2016
    Inventors: RITU BHALLA, GOPAL K. CHOTANI, MICHAEL DAUNER, MARK J. NELSON, DANIEL P. O'KEEFE, CAROLINE M. PERES, JAHNAVI CHANDRA PRASAD, JEAN-FRANCOIS TOMB
  • Publication number: 20160326552
    Abstract: The invention relates, for example, to recombinant yeast cells for differential gene expression during the propagation and production phases of a fermentation-based production process, as well as methods for using the same.
    Type: Application
    Filed: December 22, 2014
    Publication date: November 10, 2016
    Inventors: Michael DAUNER, Brian James PAUL
  • Patent number: 9441209
    Abstract: Recombinant microbial cells are disclosed herein that comprise (i) a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein, and (ii) a polyunsaturated fatty acid (PUFA) biosynthetic pathway. The down-regulation of the polynucleotide sequence encoding Sou2 sorbitol utilization protein can increase the lipid content of the microbial cells and/or decrease the total amount of sugar alcohols produced by the microbial cells. Also disclosed are methods of using the recombinant microbial cells to produce oil containing omega-3 polyunsaturated fatty acids such as EPA.
    Type: Grant
    Filed: March 17, 2015
    Date of Patent: September 13, 2016
    Assignee: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: Quinn Qun Zhu, Seung-Pyo Hong, Dongming Xie, Zhixiong Xue, Hyeryoung Yoon, Michael Dauner
  • Patent number: 9441250
    Abstract: Provided herein are glycerol-3-phosphate dehydrogenase (GPD) enzymes with increased KM for NADH and GPD enzymes with substantially the same affinity for NADH and NADPH and/or are feedback inhibited by glycerol-3-phosphate. Also provided herein are recombinant microorganisms comprising a heterologous gene encoding GPD and a deletion or disruption in an endogenous gene encoding GPD. Also provided are recombinant microorganisms comprising a heterologous gene encoding GPD and a butanol biosynthetic pathway. Further provided are methods of producing butanol comprising providing the recombinant microorganisms described herein and contacting the recombinant microorganism with at least one fermentable carbon substrate under conditions wherein butanol is produced.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: September 13, 2016
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Ritu Bhalla, Gopal K Chotani, Michael Dauner, Mark J Nelson, Daniel P O'Keefe, Caroline M Peres, Jahnavi Chandra Prasad, Jean-Francois Tomb
  • Patent number: 9181566
    Abstract: The invention relates to suitable screening strategies for evaluating various candidate promoters for differential gene expression during the propagation and production phases of a fermentation process. The invention also relates to recombinant host cells that comprise identified promoter nucleic acid sequences and methods for producing fermentation products employing the same.
    Type: Grant
    Filed: December 28, 2012
    Date of Patent: November 10, 2015
    Assignee: BUTAMAX ADVANCED BIOFUELS LLC
    Inventors: Michael Dauner, Arthur Leo Kruckeberg, Robert A Larossa, Brian James Paul, Wonchul Suh, Joseph Frederich Tuminello
  • Publication number: 20150218526
    Abstract: Recombinant microbial cells are disclosed herein that comprise (i) a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein, and (ii) a polyunsaturated fatty acid (PUFA) biosynthetic pathway. The down-regulation of the polynucleotide sequence encoding Sou2 sorbitol utilization protein can increase the lipid content of the microbial cells and/or decrease the total amount of sugar alcohols produced by the microbial cells. Also disclosed are methods of using the recombinant microbial cells to produce oil containing omega-3 polyunsaturated fatty acids such as EPA.
    Type: Application
    Filed: March 17, 2015
    Publication date: August 6, 2015
    Inventors: Quinn Qun Zhu, Seung-Pyo Hong, Dongming Xie, Zhixiong Xue, Hyeryoung Yoon, Michael Dauner
  • Publication number: 20150218597
    Abstract: The invention relates generally to the field of industrial microbiology and alcohol production. More specifically, the invention relates to the use of thiamine, biosynthetic precursors of thiamine, nicotinic acid, nicotinamid, nicotinic acid riboside, nicotinamid riboside, or other biosynthetic precursors of nicotine adenine dinucleotide (NAD) to improve butanol production. Butanol production can be improved by providing sufficient amounts of thiamine, biosynthetic precursors of thiamine, nicotinic acid, nicotinamid, nicotinic acid riboside, nicotinamid riboside, or other biosynthetic precursors of nicotine adenine dinucleotide (NAD) in the production media.
    Type: Application
    Filed: March 16, 2015
    Publication date: August 6, 2015
    Inventors: MICHAEL DAUNER, MEHMEDALIJA JAHIC
  • Patent number: 9012190
    Abstract: The invention relates generally to the field of industrial microbiology and alcohol production. More specifically, the invention relates to the use of thiamine, biosynthetic precursors of thiamine, nicotinic acid, nicotinamid, nicotinic acid riboside, nicotinamid riboside, or other biosynthetic precursors of nicotine adenine dinucleotide (NAD) to improve butanol production. Butanol production can be improved by providing sufficient amounts of thiamine, biosynthetic precursors of thiamine, nicotinic acid, nicotinamid, nicotinic acid riboside, nicotinamid riboside, or other biosynthetic precursors of nicotine adenine dinucleotide (NAD) in the production media.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: April 21, 2015
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Michael Dauner, Mehmedalija Jahic
  • Patent number: 9005940
    Abstract: Recombinant microbial cells are disclosed herein that comprise (i) a down-regulation of an endogenous polynucleotide sequence encoding Sou2 sorbitol utilization protein, and (ii) a polyunsaturated fatty acid (PUFA) biosynthetic pathway. The down-regulation of the polynucleotide sequence encoding Sou2 sorbitol utilization protein can increase the lipid content of the microbial cells and/or decrease the total amount of sugar alcohols produced by the microbial cells. Also disclosed are methods of using the recombinant microbial cells to produce oil containing omega-3 polyunsaturated fatty acids such as EPA.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: April 14, 2015
    Assignee: E I du Pont de Nemours and Company
    Inventors: Quinn Qun Zhu, Seung-Pyo Hong, Dongming Xie, Zhixiong Xue, Hyeryoung Yoon, Michael Dauner
  • Publication number: 20140349349
    Abstract: The present invention is related to recombinant host cells comprising: (i) at least one deletion, mutation, and/or substitution in an endogenous gene encoding a polypeptide that converts pyruvate to acetaldehyde, acetyl-phosphate, or acetyl-CoA; and (ii) a heterologous polynucleotide encoding a polypeptide having phosphoketolase activity. The present invention is also related to recombinant host cells further comprising (iii) a heterologous polynucleotide encoding a polypeptide having phosphotransacetylase activity.
    Type: Application
    Filed: July 18, 2014
    Publication date: November 27, 2014
    Inventors: MICHAEL DAUNER, Lori Ann Maggio-Hall, Jean-Francois Tomb
  • Patent number: 8871488
    Abstract: The present invention is related to recombinant host cells comprising: (i) at least one deletion, mutation, and/or substitution in an endogenous gene encoding a polypeptide that converts pyruvate to acetaldehyde, acetyl-phosphate or acetyl-CoA; and (ii) a heterologous polynucleotide encoding a polypeptide having phosphoketolase activity. The present invention is also related to recombinant host cells further comprising (iii) a heterologous polynucleotide encoding a polypeptide having phosphotransacetylase activity.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: October 28, 2014
    Assignee: Butamax Advanced Biofuels LLC
    Inventors: Michael Dauner, Lori Ann Maggio-Hall, Jean-Francois Tomb
  • Publication number: 20140273130
    Abstract: Provided herein are recombinant yeast host cells and methods for their use for production of fermentation products. Host cells provided herein comprise a pyruvate-utilizing pathway and a competitive growth advantage over other microorganisms in solution.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Applicant: Butamax Advanced Biofuels LLC
    Inventors: Larry Cameron ANTHONY, Michael Dauner
  • Publication number: 20140273129
    Abstract: Provided herein are glycerol-3-phosphate dehydrogenase (GPD) enzymes with increased KM for NADH and GPD enzymes with substantially the same affinity for NADH and NADPH and/or are feedback inhibited by glycerol-3-phosphate. Also provided herein are recombinant microorganisms comprising a heterologous gene encoding GPD and a deletion or disruption in an endogenous gene encoding GPD. Also provided are recombinant microorganisms comprising a heterologous gene encoding GPD and a butanol biosynthetic pathway. Further provided are methods of producing butanol comprising providing the recombinant microorganisms described herein and contacting the recombinant microorganism with at least one fermentable carbon substrate under conditions wherein butanol is produced.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: BUTAMAX ADVANCED BIOFUELS LLC
    Inventors: Ritu Bhalla, Gopal K. Chotani, Michael Dauner, Mark J. Nelson, Daniel P. O'keefe, Caroline M. Peres, Jahnavi Chandra Prasad, Jean-Francois Tomb